中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2014年
41期
3239-3243
,共5页
强光亮%郭永庆%肖飞%余其多%梁朝阳%宋之乙%田燕雏%石彬%刘德若
彊光亮%郭永慶%肖飛%餘其多%樑朝暘%宋之乙%田燕雛%石彬%劉德若
강광량%곽영경%초비%여기다%량조양%송지을%전연추%석빈%류덕약
癌,非小细胞肺%复发%因素分析,统计学
癌,非小細胞肺%複髮%因素分析,統計學
암,비소세포폐%복발%인소분석,통계학
Carcinoma,non-small-cell lung%Recurrence%Factor analysis,statistical
目的 探讨ⅢA-N2期非小细胞肺癌(NSCLC)纵隔淋巴结转移特征和完全切除术后复发的危险因素.方法 回顾性分析2001年1月至2013年12月北京中日友好医院胸外科92例接受根治性切除手术并经病理确诊为ⅢA-N2期的NSCLC患者,比较术后复发组和无复发组的临床病理资料,将可能影响预后的临床病理特征纳入Cox比例风险模型进行多因素分析.结果 术后3年和5年复发率分别为61.0%和70.2%;单因素分析提示淋巴结转移总数、淋巴结总阳性率、纵隔淋巴结转移数、纵隔淋巴结阳性率、纵隔淋巴结转移数量>3、纵隔淋巴结多站转移、跨区域转移、多区域转移是影响预后的因素,Cox多因素分析表明纵隔淋巴结跨区域转移(P =0.035)和纵隔淋巴结转移数量>3(P =0.045)是术后复发的独立危险因素.跨区域转移者复发风险是区域内转移者的2.0倍,纵隔淋巴结转移数量>3者的复发风险是1~3者的2.2倍.结论 结合纵隔淋巴结转移的位置和数量可判断ⅢA-N2期NSCLC术后复发风险,跨区域转移并且纵隔淋巴结转移数量>3者是复发风险最高的亚组.
目的 探討ⅢA-N2期非小細胞肺癌(NSCLC)縱隔淋巴結轉移特徵和完全切除術後複髮的危險因素.方法 迴顧性分析2001年1月至2013年12月北京中日友好醫院胸外科92例接受根治性切除手術併經病理確診為ⅢA-N2期的NSCLC患者,比較術後複髮組和無複髮組的臨床病理資料,將可能影響預後的臨床病理特徵納入Cox比例風險模型進行多因素分析.結果 術後3年和5年複髮率分彆為61.0%和70.2%;單因素分析提示淋巴結轉移總數、淋巴結總暘性率、縱隔淋巴結轉移數、縱隔淋巴結暘性率、縱隔淋巴結轉移數量>3、縱隔淋巴結多站轉移、跨區域轉移、多區域轉移是影響預後的因素,Cox多因素分析錶明縱隔淋巴結跨區域轉移(P =0.035)和縱隔淋巴結轉移數量>3(P =0.045)是術後複髮的獨立危險因素.跨區域轉移者複髮風險是區域內轉移者的2.0倍,縱隔淋巴結轉移數量>3者的複髮風險是1~3者的2.2倍.結論 結閤縱隔淋巴結轉移的位置和數量可判斷ⅢA-N2期NSCLC術後複髮風險,跨區域轉移併且縱隔淋巴結轉移數量>3者是複髮風險最高的亞組.
목적 탐토ⅢA-N2기비소세포폐암(NSCLC)종격림파결전이특정화완전절제술후복발적위험인소.방법 회고성분석2001년1월지2013년12월북경중일우호의원흉외과92례접수근치성절제수술병경병리학진위ⅢA-N2기적NSCLC환자,비교술후복발조화무복발조적림상병리자료,장가능영향예후적림상병리특정납입Cox비례풍험모형진행다인소분석.결과 술후3년화5년복발솔분별위61.0%화70.2%;단인소분석제시림파결전이총수、림파결총양성솔、종격림파결전이수、종격림파결양성솔、종격림파결전이수량>3、종격림파결다참전이、과구역전이、다구역전이시영향예후적인소,Cox다인소분석표명종격림파결과구역전이(P =0.035)화종격림파결전이수량>3(P =0.045)시술후복발적독립위험인소.과구역전이자복발풍험시구역내전이자적2.0배,종격림파결전이수량>3자적복발풍험시1~3자적2.2배.결론 결합종격림파결전이적위치화수량가판단ⅢA-N2기NSCLC술후복발풍험,과구역전이병차종격림파결전이수량>3자시복발풍험최고적아조.
Objective To explore the patterns of mediastinal lymph node metastases and prognostic factors of recurrence in patients undergoing curative resection of stage Ⅲ A-N2 non-small cell lung cancer (NSCLC).Methods A total of 92 patients underwent curative operation and pathologically diagnosed as stage Ⅲ A-N2 NSCLC were retrospectively reviewed.The clinicopathological data were compared between the recurrence and non-recurrence groups.And the potential prognostic factors were included for multivariate analysis using Cox proportional hazard model.Results The 3 and 5-year recurrence rates were 61.0% and 70.2% respectively.For univariate analysis,the prognostic factors were number of metastatic lymph nodes,positive lymph node ratio,number of metastatic mediastinal lymph nodes (MLN),positive MLN ratio,number of MLN metastasis > 3,multiple station metastasis,trans-regional metastasis and multi-zonal metastasis.A multivariate analysis using Cox regression identified 2 independent factors of prognosis:transregional MLN metastasis (P =0.035) and number of MLN metastasis > 3 (P =0.045).The recurrence risk of patients with trans-regional MLN metastasis was 2.0 times higher than those with regional MLN metastasis while the recurrence risk of patients with number of MLN metastasis > 3 was 2.2 times higher than those with number of MLN metastasis of 1-3.Conclusion Recurrence risk of stage Ⅲ A-N2 non-small cell lung cancer (NSCLC) after curative resection may be estimated by location and number of MLN metastasis.And the subgroup with trans-regional MLN metastasis and number of MLN metastasis > 3 carries the highest risk of recurrence.